Skip to main content
. 2021 Apr 9;35(9):1333–1342. doi: 10.1097/QAD.0000000000002883

Fig. 2.

Cabotegravir and rilpivirine trough concentrations at Week 8 (i.e. 4 weeks after first injections) and CVF through Week 48 (pooled Phase 3/3b) by regimen (a) and baseline BMI category (b).

Fig. 2

The median (Q1, Q3) for Week 8 RPV trough concentration is 41.50 (32.10, 54.30) and for Week 8 CAB trough concentration is 1.61 (1.12, 2.10). CAB, cabotegravir; CVF, confirmed virologic failure; Q1, first quartile; Q3, third quartile; Q4W, every 4 weeks; Q8W, every 8 weeks; RPV, rilpivirine. The median (Q1, Q3) for Week 8 RPV trough concentration is 41.50 (32.10, 54.30) and for Week 8 CAB trough concentration is 1.61 (1.12, 2.10). BMI (kg/m2); CAB, cabotegravir; CVF, confirmed virologic failure; Q1, first quartile; Q3, third quartile; RPV, rilpivirine.